Navigation Links
Beckman Coulter's 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
Date:2/8/2008

viewing aspects of our operations that when viewed with our GAAP results provide a more complete understanding of factors and trends affecting our business. However, investors should understand that the excluded items are actual income and expenses that may impact the cash available to us for other uses. We strongly encourage investors to consider both net earnings and cash flows determined under GAAP as compared to the non-GAAP measures presented and to perform their own analysis, as appropriate.

BECKMAN COULTER, INC.

CONSOLIDATED STATEMENTS OF EARNINGS

(in millions, except amounts per share and share data)

(unaudited)

Quarter Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Product revenue $674.3 $608.0 $2,331.9 $2,130.5

Service revenue 114.7 104.0 429.4 398.0

Total revenue 789.0 712.0 2,761.3 2,528.5

Cost of goods sold 338.6 307.2 1,153.7 1,048.2

Cost of service 80.9 71.2 312.4 283.3

Total cost of sales 419.5 378.4 1,466.1 1,331.5

Gross profit 369.5 333.6 1,295.2 1,197.0

Operating costs and

expenses

Selling, general

and administrative 193.2 172.6 731.1 687.6

Research and

development 97.5 57.6 274.0 264.9

Restructuring 4.2 2.6 16.9 14.3

Asset impairment

charges - - 0.8 2.3

Litigation settlement - - - (35.0)

T
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
4. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
5. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
6. Haemacure Reports Third Quarter 2007 Results
7. Weight Watchers Declares Quarterly Dividend
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. Medical Services International Maintains Pace in Second Quarter
11. Martek Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ersity College of Medicine research team led by Ya...of regulation in the cell division cycle, which co...cer begins. , Wang, an assistant professor of bi... the findings will lead to an improved ability to ...w drugs that kill cancer cells by inhibiting cell ...
(Date:11/21/2008)... -- The Providence Service,Corporation (Nasdaq: ...Company,s,Chief Operating Officer, has been appoi...rris, appointment fills the vacancy left by the Ap...turns the board to six members. Mr.,Norris will ...Mr. Norris, age 41, has been with Providence since...
(Date:11/21/2008)...ue to combat cancer, study says, , , ...chers have discovered that some cancer cells use l...ht lead to new treatments that starve and kill the...ls in the body need to produce energy. They do thi...res oxygen. Compared with normal cells, tumor cell...
(Date:11/21/2008)...ct Investment And Restore Shareholder Value , ...- Dr. Stephen Joffe, Craig Joffe, and Alan Buckey ...h the U.S. Securities and Exchange Commission. Th...p of 11.4% of LCA-Vision, Inc. (Nasdaq: LCAV ), ...n correction centers in 33 states in the United St...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...the women, who received cognitive behavioral thera... for suicide. Women given cognitive behavioral th...en who were treated by expert therapists - said Ma...e study. In addition, the women who received the...
...herside Hospital is being investigated by the Gard...r she apparently became caught in the straps of he...ting with the investigation and will launch its ow...lity in Cork. The HSE added that the hospital has ...
...a tentative New Drug Approval from USFDA for its f...V-1 infection//. The new drug approval is for fi...udine, Zidovudine, Nevirapine tablets used in the ...n, the company informed the Bombay Stock Exchange....
...njecting cattle with many growth hormones that are...ncern among EU nations that import beef, necessita...ment expert and a pharmaceutical chemist, John Ver...effects of consuming beef from cattle that have be...
Other Medicine News:Health News:Special Behavioral Therapies made Women more likely to Attempt Suicide 2Health News:Special Behavioral Therapies made Women more likely to Attempt Suicide 3
(Date:11/19/2008)...scientists report basic findings on critical enzym...o better treat an array of disorders , , ME...Scientists at St. Jude Children,s Research Hospita...of the body,s enzyme workhorses called calpains. ...calpains function in many cellular processes, incl...
(Date:11/19/2008)...el., Nov. 19 Isogen, a contract de...ile filling, today announced the first,phase laun...s founded to,specifically address the process, fa...with the $2 billion highly-niched, low-volume clin...arket segment. , Companies can invest over ...
(Date:11/18/2008)...ovember 19 NeuroDiscover...e provider and drug development Company,and Sose...565), a leading,international biopharmaceutical c...senting further pivotal pre-clinical efficacy data...a potential therapy for neuropathic pain and has,...
(Date:11/18/2008)...Pa., Nov. 18 Arlington Medical Res...igence for the pharmaceutical and diagnostic,imag... Behring,s Privigen was,sold in the U.S. during t...brand of intravenous immune globulin (IVIG) and wa...a product created from the blood plasma of thousan...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 2069 1Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 2069 2Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 2069 3Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 2069 4Good Clean Foods New Line of All Natural Simmer Sauces for Chicken Hits Market Shelves 7589 1Good Clean Foods New Line of All Natural Simmer Sauces for Chicken Hits Market Shelves 7589 2Good Clean Foods New Line of All Natural Simmer Sauces for Chicken Hits Market Shelves 7589 3Tubbs Jones Commemorates World AIDS Day 7587 1Tubbs Jones Commemorates World AIDS Day 7587 2Updated Analysis of 2001 Epoetin Alfa Study Posted 7584 1Updated Analysis of 2001 Epoetin Alfa Study Posted 7584 2Updated Analysis of 2001 Epoetin Alfa Study Posted 7584 3Updated Analysis of 2001 Epoetin Alfa Study Posted 7584 4Updated Analysis of 2001 Epoetin Alfa Study Posted 7584 5
...uable Patients Receiving Combination of,Bavituxima...r Response or Stable Disease - , - 75% of Patie...itabine , ,Achieved Objective Tumor Resp...nts Receiving Combination of Bavituximab Plus , ...umor Response - , - Trial Results Support Ad...
...nd GAITHERSBURG, Md., May 31, 2007 (PRIME,NEWSWIRE...and,MedImmune, Inc. (Nasdaq:MEDI) today announced ... trial in patients with,gastrointestinal stromal t... will be presented at the 2007 Annual Meeting of t...o be held June 1-5,2007 at McCormick Place in Chi...
Other Medicine Technology:Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 2Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 3Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 4Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 5Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 2Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 3Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 4Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 5
... gives you the detailed information you need to ma...ents with palpitations, syncope and intermittent c...em, this transtelephonic cardiac event monitor req... ECG. Comfortable for your patients to wear and si...
...ATION enhances patient care management by providin...port, and clinical reporting from anywhere in the ...System, the MULTIVIEW WORKSTATION provides compreh...real-time patient vital signs and hemodynamics, re...
The biograph 2 offers the ultimate PET/CT performance for improved disease diagnosis and treatment in oncology, neurology, and cardiology. It delivers high-quality PET/CT whole body scans in less tha
... the highly respected single-source CT solution, f...alizing plaque. With its proprietary STRATON X-ray...tion time of 0.33s, virtually freezing the hearts ...he system delivers unprecedented diagnostic detail...
Medicine Products: